Skip to main content

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in ANTX — AN2 Therapeutics, Inc.

CIK 1107261 HOUSTON, TX

Position in ANTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$289,916
+$85,058 QoQ
Shares Held
59,900
0.0% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 66 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. ANTX ranks #65 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $289,916 59,900
2026-03-31 $204,858 59,900
2025-12-31 $68,286 59,900
2025-09-30 $76,073 59,900
2025-06-30 $63,494 59,900
2025-03-31 $81,464 59,900
2024-12-31 $223,836 162,200
2024-09-30 $210,790 197,000
2024-06-30 $224,227 104,292
2024-03-31 $85,449 26,292
2023-12-31 $757,966 36,992
2023-09-30 $763,800 47,500
2023-06-30 $233,750 27,500
2023-03-31 $518,175 52,500